Global Non-Invasive Drug Delivery Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Non-Invasive Drug Delivery Industry Forecast” looks at past sales and reviews total world Non-Invasive Drug Delivery sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-Invasive Drug Delivery sales for 2023 through 2029. With Non-Invasive Drug Delivery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Invasive Drug Delivery industry.
This Insight Report provides a comprehensive analysis of the global Non-Invasive Drug Delivery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-Invasive Drug Delivery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-Invasive Drug Delivery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Invasive Drug Delivery and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Invasive Drug Delivery.
The global Non-Invasive Drug Delivery market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Non-Invasive Drug Delivery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Non-Invasive Drug Delivery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Non-Invasive Drug Delivery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Non-Invasive Drug Delivery players cover Adherium Limited, Capsule Technologies, Inc., Crossject S.A., Diabeloop SA, HNS International, Inc., Inovio Pharmaceuticals, Inc., Medtronic Plc., Novartis AG and PenJet Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Invasive Drug Delivery market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Non-Invasive Drug Delivery Industry Forecast” looks at past sales and reviews total world Non-Invasive Drug Delivery sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-Invasive Drug Delivery sales for 2023 through 2029. With Non-Invasive Drug Delivery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Invasive Drug Delivery industry.
This Insight Report provides a comprehensive analysis of the global Non-Invasive Drug Delivery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-Invasive Drug Delivery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-Invasive Drug Delivery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Invasive Drug Delivery and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Invasive Drug Delivery.
The global Non-Invasive Drug Delivery market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Non-Invasive Drug Delivery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Non-Invasive Drug Delivery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Non-Invasive Drug Delivery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Non-Invasive Drug Delivery players cover Adherium Limited, Capsule Technologies, Inc., Crossject S.A., Diabeloop SA, HNS International, Inc., Inovio Pharmaceuticals, Inc., Medtronic Plc., Novartis AG and PenJet Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Invasive Drug Delivery market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Artificial Pancreas
- Needle Free Injector
- Digital Respiratory Devices
- Other
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Adherium Limited
- Capsule Technologies, Inc.
- Crossject S.A.
- Diabeloop SA
- HNS International, Inc.
- Inovio Pharmaceuticals, Inc.
- Medtronic Plc.
- Novartis AG
- PenJet Corporation
- PharmaJet
- Portal Instruments
- ResMed
- Sensiron AG
- Tandem Diabetes Care, Inc.
- Teva Pharmaceuticals Industries Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-Invasive Drug Delivery Market Size 2018-2029
2.1.2 Non-Invasive Drug Delivery Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Non-Invasive Drug Delivery Segment by Type
2.2.1 Artificial Pancreas
2.2.2 Needle Free Injector
2.2.3 Digital Respiratory Devices
2.2.4 Other
2.3 Non-Invasive Drug Delivery Market Size by Type
2.3.1 Non-Invasive Drug Delivery Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Non-Invasive Drug Delivery Market Size Market Share by Type (2018-2023)
2.4 Non-Invasive Drug Delivery Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Non-Invasive Drug Delivery Market Size by Application
2.5.1 Non-Invasive Drug Delivery Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Non-Invasive Drug Delivery Market Size Market Share by Application (2018-2023)
3 NON-INVASIVE DRUG DELIVERY MARKET SIZE BY PLAYER
3.1 Non-Invasive Drug Delivery Market Size Market Share by Players
3.1.1 Global Non-Invasive Drug Delivery Revenue by Players (2018-2023)
3.1.2 Global Non-Invasive Drug Delivery Revenue Market Share by Players (2018-2023)
3.2 Global Non-Invasive Drug Delivery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-INVASIVE DRUG DELIVERY BY REGIONS
4.1 Non-Invasive Drug Delivery Market Size by Regions (2018-2023)
4.2 Americas Non-Invasive Drug Delivery Market Size Growth (2018-2023)
4.3 APAC Non-Invasive Drug Delivery Market Size Growth (2018-2023)
4.4 Europe Non-Invasive Drug Delivery Market Size Growth (2018-2023)
4.5 Middle East & Africa Non-Invasive Drug Delivery Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Non-Invasive Drug Delivery Market Size by Country (2018-2023)
5.2 Americas Non-Invasive Drug Delivery Market Size by Type (2018-2023)
5.3 Americas Non-Invasive Drug Delivery Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Invasive Drug Delivery Market Size by Region (2018-2023)
6.2 APAC Non-Invasive Drug Delivery Market Size by Type (2018-2023)
6.3 APAC Non-Invasive Drug Delivery Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-Invasive Drug Delivery by Country (2018-2023)
7.2 Europe Non-Invasive Drug Delivery Market Size by Type (2018-2023)
7.3 Europe Non-Invasive Drug Delivery Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-Invasive Drug Delivery by Region (2018-2023)
8.2 Middle East & Africa Non-Invasive Drug Delivery Market Size by Type (2018-2023)
8.3 Middle East & Africa Non-Invasive Drug Delivery Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-INVASIVE DRUG DELIVERY MARKET FORECAST
10.1 Global Non-Invasive Drug Delivery Forecast by Regions (2024-2029)
10.1.1 Global Non-Invasive Drug Delivery Forecast by Regions (2024-2029)
10.1.2 Americas Non-Invasive Drug Delivery Forecast
10.1.3 APAC Non-Invasive Drug Delivery Forecast
10.1.4 Europe Non-Invasive Drug Delivery Forecast
10.1.5 Middle East & Africa Non-Invasive Drug Delivery Forecast
10.2 Americas Non-Invasive Drug Delivery Forecast by Country (2024-2029)
10.2.1 United States Non-Invasive Drug Delivery Market Forecast
10.2.2 Canada Non-Invasive Drug Delivery Market Forecast
10.2.3 Mexico Non-Invasive Drug Delivery Market Forecast
10.2.4 Brazil Non-Invasive Drug Delivery Market Forecast
10.3 APAC Non-Invasive Drug Delivery Forecast by Region (2024-2029)
10.3.1 China Non-Invasive Drug Delivery Market Forecast
10.3.2 Japan Non-Invasive Drug Delivery Market Forecast
10.3.3 Korea Non-Invasive Drug Delivery Market Forecast
10.3.4 Southeast Asia Non-Invasive Drug Delivery Market Forecast
10.3.5 India Non-Invasive Drug Delivery Market Forecast
10.3.6 Australia Non-Invasive Drug Delivery Market Forecast
10.4 Europe Non-Invasive Drug Delivery Forecast by Country (2024-2029)
10.4.1 Germany Non-Invasive Drug Delivery Market Forecast
10.4.2 France Non-Invasive Drug Delivery Market Forecast
10.4.3 UK Non-Invasive Drug Delivery Market Forecast
10.4.4 Italy Non-Invasive Drug Delivery Market Forecast
10.4.5 Russia Non-Invasive Drug Delivery Market Forecast
10.5 Middle East & Africa Non-Invasive Drug Delivery Forecast by Region (2024-2029)
10.5.1 Egypt Non-Invasive Drug Delivery Market Forecast
10.5.2 South Africa Non-Invasive Drug Delivery Market Forecast
10.5.3 Israel Non-Invasive Drug Delivery Market Forecast
10.5.4 Turkey Non-Invasive Drug Delivery Market Forecast
10.5.5 GCC Countries Non-Invasive Drug Delivery Market Forecast
10.6 Global Non-Invasive Drug Delivery Forecast by Type (2024-2029)
10.7 Global Non-Invasive Drug Delivery Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Adherium Limited
11.1.1 Adherium Limited Company Information
11.1.2 Adherium Limited Non-Invasive Drug Delivery Product Offered
11.1.3 Adherium Limited Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Adherium Limited Main Business Overview
11.1.5 Adherium Limited Latest Developments
11.2 Capsule Technologies, Inc.
11.2.1 Capsule Technologies, Inc. Company Information
11.2.2 Capsule Technologies, Inc. Non-Invasive Drug Delivery Product Offered
11.2.3 Capsule Technologies, Inc. Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Capsule Technologies, Inc. Main Business Overview
11.2.5 Capsule Technologies, Inc. Latest Developments
11.3 Crossject S.A.
11.3.1 Crossject S.A. Company Information
11.3.2 Crossject S.A. Non-Invasive Drug Delivery Product Offered
11.3.3 Crossject S.A. Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Crossject S.A. Main Business Overview
11.3.5 Crossject S.A. Latest Developments
11.4 Diabeloop SA
11.4.1 Diabeloop SA Company Information
11.4.2 Diabeloop SA Non-Invasive Drug Delivery Product Offered
11.4.3 Diabeloop SA Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Diabeloop SA Main Business Overview
11.4.5 Diabeloop SA Latest Developments
11.5 HNS International, Inc.
11.5.1 HNS International, Inc. Company Information
11.5.2 HNS International, Inc. Non-Invasive Drug Delivery Product Offered
11.5.3 HNS International, Inc. Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 HNS International, Inc. Main Business Overview
11.5.5 HNS International, Inc. Latest Developments
11.6 Inovio Pharmaceuticals, Inc.
11.6.1 Inovio Pharmaceuticals, Inc. Company Information
11.6.2 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product Offered
11.6.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Inovio Pharmaceuticals, Inc. Main Business Overview
11.6.5 Inovio Pharmaceuticals, Inc. Latest Developments
11.7 Medtronic Plc.
11.7.1 Medtronic Plc. Company Information
11.7.2 Medtronic Plc. Non-Invasive Drug Delivery Product Offered
11.7.3 Medtronic Plc. Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Medtronic Plc. Main Business Overview
11.7.5 Medtronic Plc. Latest Developments
11.8 Novartis AG
11.8.1 Novartis AG Company Information
11.8.2 Novartis AG Non-Invasive Drug Delivery Product Offered
11.8.3 Novartis AG Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Novartis AG Main Business Overview
11.8.5 Novartis AG Latest Developments
11.9 PenJet Corporation
11.9.1 PenJet Corporation Company Information
11.9.2 PenJet Corporation Non-Invasive Drug Delivery Product Offered
11.9.3 PenJet Corporation Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 PenJet Corporation Main Business Overview
11.9.5 PenJet Corporation Latest Developments
11.10 PharmaJet
11.10.1 PharmaJet Company Information
11.10.2 PharmaJet Non-Invasive Drug Delivery Product Offered
11.10.3 PharmaJet Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 PharmaJet Main Business Overview
11.10.5 PharmaJet Latest Developments
11.11 Portal Instruments
11.11.1 Portal Instruments Company Information
11.11.2 Portal Instruments Non-Invasive Drug Delivery Product Offered
11.11.3 Portal Instruments Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Portal Instruments Main Business Overview
11.11.5 Portal Instruments Latest Developments
11.12 ResMed
11.12.1 ResMed Company Information
11.12.2 ResMed Non-Invasive Drug Delivery Product Offered
11.12.3 ResMed Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 ResMed Main Business Overview
11.12.5 ResMed Latest Developments
11.13 Sensiron AG
11.13.1 Sensiron AG Company Information
11.13.2 Sensiron AG Non-Invasive Drug Delivery Product Offered
11.13.3 Sensiron AG Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Sensiron AG Main Business Overview
11.13.5 Sensiron AG Latest Developments
11.14 Tandem Diabetes Care, Inc.
11.14.1 Tandem Diabetes Care, Inc. Company Information
11.14.2 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product Offered
11.14.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Tandem Diabetes Care, Inc. Main Business Overview
11.14.5 Tandem Diabetes Care, Inc. Latest Developments
11.15 Teva Pharmaceuticals Industries Ltd.
11.15.1 Teva Pharmaceuticals Industries Ltd. Company Information
11.15.2 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product Offered
11.15.3 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Teva Pharmaceuticals Industries Ltd. Main Business Overview
11.15.5 Teva Pharmaceuticals Industries Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-Invasive Drug Delivery Market Size 2018-2029
2.1.2 Non-Invasive Drug Delivery Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Non-Invasive Drug Delivery Segment by Type
2.2.1 Artificial Pancreas
2.2.2 Needle Free Injector
2.2.3 Digital Respiratory Devices
2.2.4 Other
2.3 Non-Invasive Drug Delivery Market Size by Type
2.3.1 Non-Invasive Drug Delivery Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Non-Invasive Drug Delivery Market Size Market Share by Type (2018-2023)
2.4 Non-Invasive Drug Delivery Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Non-Invasive Drug Delivery Market Size by Application
2.5.1 Non-Invasive Drug Delivery Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Non-Invasive Drug Delivery Market Size Market Share by Application (2018-2023)
3 NON-INVASIVE DRUG DELIVERY MARKET SIZE BY PLAYER
3.1 Non-Invasive Drug Delivery Market Size Market Share by Players
3.1.1 Global Non-Invasive Drug Delivery Revenue by Players (2018-2023)
3.1.2 Global Non-Invasive Drug Delivery Revenue Market Share by Players (2018-2023)
3.2 Global Non-Invasive Drug Delivery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-INVASIVE DRUG DELIVERY BY REGIONS
4.1 Non-Invasive Drug Delivery Market Size by Regions (2018-2023)
4.2 Americas Non-Invasive Drug Delivery Market Size Growth (2018-2023)
4.3 APAC Non-Invasive Drug Delivery Market Size Growth (2018-2023)
4.4 Europe Non-Invasive Drug Delivery Market Size Growth (2018-2023)
4.5 Middle East & Africa Non-Invasive Drug Delivery Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Non-Invasive Drug Delivery Market Size by Country (2018-2023)
5.2 Americas Non-Invasive Drug Delivery Market Size by Type (2018-2023)
5.3 Americas Non-Invasive Drug Delivery Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Invasive Drug Delivery Market Size by Region (2018-2023)
6.2 APAC Non-Invasive Drug Delivery Market Size by Type (2018-2023)
6.3 APAC Non-Invasive Drug Delivery Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-Invasive Drug Delivery by Country (2018-2023)
7.2 Europe Non-Invasive Drug Delivery Market Size by Type (2018-2023)
7.3 Europe Non-Invasive Drug Delivery Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-Invasive Drug Delivery by Region (2018-2023)
8.2 Middle East & Africa Non-Invasive Drug Delivery Market Size by Type (2018-2023)
8.3 Middle East & Africa Non-Invasive Drug Delivery Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-INVASIVE DRUG DELIVERY MARKET FORECAST
10.1 Global Non-Invasive Drug Delivery Forecast by Regions (2024-2029)
10.1.1 Global Non-Invasive Drug Delivery Forecast by Regions (2024-2029)
10.1.2 Americas Non-Invasive Drug Delivery Forecast
10.1.3 APAC Non-Invasive Drug Delivery Forecast
10.1.4 Europe Non-Invasive Drug Delivery Forecast
10.1.5 Middle East & Africa Non-Invasive Drug Delivery Forecast
10.2 Americas Non-Invasive Drug Delivery Forecast by Country (2024-2029)
10.2.1 United States Non-Invasive Drug Delivery Market Forecast
10.2.2 Canada Non-Invasive Drug Delivery Market Forecast
10.2.3 Mexico Non-Invasive Drug Delivery Market Forecast
10.2.4 Brazil Non-Invasive Drug Delivery Market Forecast
10.3 APAC Non-Invasive Drug Delivery Forecast by Region (2024-2029)
10.3.1 China Non-Invasive Drug Delivery Market Forecast
10.3.2 Japan Non-Invasive Drug Delivery Market Forecast
10.3.3 Korea Non-Invasive Drug Delivery Market Forecast
10.3.4 Southeast Asia Non-Invasive Drug Delivery Market Forecast
10.3.5 India Non-Invasive Drug Delivery Market Forecast
10.3.6 Australia Non-Invasive Drug Delivery Market Forecast
10.4 Europe Non-Invasive Drug Delivery Forecast by Country (2024-2029)
10.4.1 Germany Non-Invasive Drug Delivery Market Forecast
10.4.2 France Non-Invasive Drug Delivery Market Forecast
10.4.3 UK Non-Invasive Drug Delivery Market Forecast
10.4.4 Italy Non-Invasive Drug Delivery Market Forecast
10.4.5 Russia Non-Invasive Drug Delivery Market Forecast
10.5 Middle East & Africa Non-Invasive Drug Delivery Forecast by Region (2024-2029)
10.5.1 Egypt Non-Invasive Drug Delivery Market Forecast
10.5.2 South Africa Non-Invasive Drug Delivery Market Forecast
10.5.3 Israel Non-Invasive Drug Delivery Market Forecast
10.5.4 Turkey Non-Invasive Drug Delivery Market Forecast
10.5.5 GCC Countries Non-Invasive Drug Delivery Market Forecast
10.6 Global Non-Invasive Drug Delivery Forecast by Type (2024-2029)
10.7 Global Non-Invasive Drug Delivery Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Adherium Limited
11.1.1 Adherium Limited Company Information
11.1.2 Adherium Limited Non-Invasive Drug Delivery Product Offered
11.1.3 Adherium Limited Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Adherium Limited Main Business Overview
11.1.5 Adherium Limited Latest Developments
11.2 Capsule Technologies, Inc.
11.2.1 Capsule Technologies, Inc. Company Information
11.2.2 Capsule Technologies, Inc. Non-Invasive Drug Delivery Product Offered
11.2.3 Capsule Technologies, Inc. Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Capsule Technologies, Inc. Main Business Overview
11.2.5 Capsule Technologies, Inc. Latest Developments
11.3 Crossject S.A.
11.3.1 Crossject S.A. Company Information
11.3.2 Crossject S.A. Non-Invasive Drug Delivery Product Offered
11.3.3 Crossject S.A. Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Crossject S.A. Main Business Overview
11.3.5 Crossject S.A. Latest Developments
11.4 Diabeloop SA
11.4.1 Diabeloop SA Company Information
11.4.2 Diabeloop SA Non-Invasive Drug Delivery Product Offered
11.4.3 Diabeloop SA Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Diabeloop SA Main Business Overview
11.4.5 Diabeloop SA Latest Developments
11.5 HNS International, Inc.
11.5.1 HNS International, Inc. Company Information
11.5.2 HNS International, Inc. Non-Invasive Drug Delivery Product Offered
11.5.3 HNS International, Inc. Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 HNS International, Inc. Main Business Overview
11.5.5 HNS International, Inc. Latest Developments
11.6 Inovio Pharmaceuticals, Inc.
11.6.1 Inovio Pharmaceuticals, Inc. Company Information
11.6.2 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product Offered
11.6.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Inovio Pharmaceuticals, Inc. Main Business Overview
11.6.5 Inovio Pharmaceuticals, Inc. Latest Developments
11.7 Medtronic Plc.
11.7.1 Medtronic Plc. Company Information
11.7.2 Medtronic Plc. Non-Invasive Drug Delivery Product Offered
11.7.3 Medtronic Plc. Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Medtronic Plc. Main Business Overview
11.7.5 Medtronic Plc. Latest Developments
11.8 Novartis AG
11.8.1 Novartis AG Company Information
11.8.2 Novartis AG Non-Invasive Drug Delivery Product Offered
11.8.3 Novartis AG Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Novartis AG Main Business Overview
11.8.5 Novartis AG Latest Developments
11.9 PenJet Corporation
11.9.1 PenJet Corporation Company Information
11.9.2 PenJet Corporation Non-Invasive Drug Delivery Product Offered
11.9.3 PenJet Corporation Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 PenJet Corporation Main Business Overview
11.9.5 PenJet Corporation Latest Developments
11.10 PharmaJet
11.10.1 PharmaJet Company Information
11.10.2 PharmaJet Non-Invasive Drug Delivery Product Offered
11.10.3 PharmaJet Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 PharmaJet Main Business Overview
11.10.5 PharmaJet Latest Developments
11.11 Portal Instruments
11.11.1 Portal Instruments Company Information
11.11.2 Portal Instruments Non-Invasive Drug Delivery Product Offered
11.11.3 Portal Instruments Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Portal Instruments Main Business Overview
11.11.5 Portal Instruments Latest Developments
11.12 ResMed
11.12.1 ResMed Company Information
11.12.2 ResMed Non-Invasive Drug Delivery Product Offered
11.12.3 ResMed Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 ResMed Main Business Overview
11.12.5 ResMed Latest Developments
11.13 Sensiron AG
11.13.1 Sensiron AG Company Information
11.13.2 Sensiron AG Non-Invasive Drug Delivery Product Offered
11.13.3 Sensiron AG Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Sensiron AG Main Business Overview
11.13.5 Sensiron AG Latest Developments
11.14 Tandem Diabetes Care, Inc.
11.14.1 Tandem Diabetes Care, Inc. Company Information
11.14.2 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product Offered
11.14.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Tandem Diabetes Care, Inc. Main Business Overview
11.14.5 Tandem Diabetes Care, Inc. Latest Developments
11.15 Teva Pharmaceuticals Industries Ltd.
11.15.1 Teva Pharmaceuticals Industries Ltd. Company Information
11.15.2 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product Offered
11.15.3 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Teva Pharmaceuticals Industries Ltd. Main Business Overview
11.15.5 Teva Pharmaceuticals Industries Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-Invasive Drug Delivery Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Artificial Pancreas
Table 3. Major Players of Needle Free Injector
Table 4. Major Players of Digital Respiratory Devices
Table 5. Major Players of Other
Table 6. Non-Invasive Drug Delivery Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Non-Invasive Drug Delivery Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Non-Invasive Drug Delivery Market Size Market Share by Type (2018-2023)
Table 9. Non-Invasive Drug Delivery Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Non-Invasive Drug Delivery Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Non-Invasive Drug Delivery Market Size Market Share by Application (2018-2023)
Table 12. Global Non-Invasive Drug Delivery Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Non-Invasive Drug Delivery Revenue Market Share by Player (2018-2023)
Table 14. Non-Invasive Drug Delivery Key Players Head office and Products Offered
Table 15. Non-Invasive Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Non-Invasive Drug Delivery Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Non-Invasive Drug Delivery Market Size Market Share by Regions (2018-2023)
Table 20. Global Non-Invasive Drug Delivery Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Non-Invasive Drug Delivery Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Non-Invasive Drug Delivery Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Non-Invasive Drug Delivery Market Size Market Share by Country (2018-2023)
Table 24. Americas Non-Invasive Drug Delivery Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Non-Invasive Drug Delivery Market Size Market Share by Type (2018-2023)
Table 26. Americas Non-Invasive Drug Delivery Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Non-Invasive Drug Delivery Market Size Market Share by Application (2018-2023)
Table 28. APAC Non-Invasive Drug Delivery Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Non-Invasive Drug Delivery Market Size Market Share by Region (2018-2023)
Table 30. APAC Non-Invasive Drug Delivery Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Non-Invasive Drug Delivery Market Size Market Share by Type (2018-2023)
Table 32. APAC Non-Invasive Drug Delivery Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Non-Invasive Drug Delivery Market Size Market Share by Application (2018-2023)
Table 34. Europe Non-Invasive Drug Delivery Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Non-Invasive Drug Delivery Market Size Market Share by Country (2018-2023)
Table 36. Europe Non-Invasive Drug Delivery Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Non-Invasive Drug Delivery Market Size Market Share by Type (2018-2023)
Table 38. Europe Non-Invasive Drug Delivery Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Non-Invasive Drug Delivery Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Non-Invasive Drug Delivery Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Non-Invasive Drug Delivery Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Non-Invasive Drug Delivery Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Non-Invasive Drug Delivery Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Non-Invasive Drug Delivery Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Non-Invasive Drug Delivery Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Non-Invasive Drug Delivery
Table 47. Key Market Challenges & Risks of Non-Invasive Drug Delivery
Table 48. Key Industry Trends of Non-Invasive Drug Delivery
Table 49. Global Non-Invasive Drug Delivery Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Non-Invasive Drug Delivery Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Non-Invasive Drug Delivery Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Non-Invasive Drug Delivery Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Adherium Limited Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 54. Adherium Limited Non-Invasive Drug Delivery Product Offered
Table 55. Adherium Limited Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Adherium Limited Main Business
Table 57. Adherium Limited Latest Developments
Table 58. Capsule Technologies, Inc. Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 59. Capsule Technologies, Inc. Non-Invasive Drug Delivery Product Offered
Table 60. Capsule Technologies, Inc. Main Business
Table 61. Capsule Technologies, Inc. Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Capsule Technologies, Inc. Latest Developments
Table 63. Crossject S.A. Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 64. Crossject S.A. Non-Invasive Drug Delivery Product Offered
Table 65. Crossject S.A. Main Business
Table 66. Crossject S.A. Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Crossject S.A. Latest Developments
Table 68. Diabeloop SA Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 69. Diabeloop SA Non-Invasive Drug Delivery Product Offered
Table 70. Diabeloop SA Main Business
Table 71. Diabeloop SA Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Diabeloop SA Latest Developments
Table 73. HNS International, Inc. Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 74. HNS International, Inc. Non-Invasive Drug Delivery Product Offered
Table 75. HNS International, Inc. Main Business
Table 76. HNS International, Inc. Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. HNS International, Inc. Latest Developments
Table 78. Inovio Pharmaceuticals, Inc. Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 79. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product Offered
Table 80. Inovio Pharmaceuticals, Inc. Main Business
Table 81. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Inovio Pharmaceuticals, Inc. Latest Developments
Table 83. Medtronic Plc. Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 84. Medtronic Plc. Non-Invasive Drug Delivery Product Offered
Table 85. Medtronic Plc. Main Business
Table 86. Medtronic Plc. Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Medtronic Plc. Latest Developments
Table 88. Novartis AG Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 89. Novartis AG Non-Invasive Drug Delivery Product Offered
Table 90. Novartis AG Main Business
Table 91. Novartis AG Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Novartis AG Latest Developments
Table 93. PenJet Corporation Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 94. PenJet Corporation Non-Invasive Drug Delivery Product Offered
Table 95. PenJet Corporation Main Business
Table 96. PenJet Corporation Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. PenJet Corporation Latest Developments
Table 98. PharmaJet Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 99. PharmaJet Non-Invasive Drug Delivery Product Offered
Table 100. PharmaJet Main Business
Table 101. PharmaJet Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. PharmaJet Latest Developments
Table 103. Portal Instruments Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 104. Portal Instruments Non-Invasive Drug Delivery Product Offered
Table 105. Portal Instruments Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Portal Instruments Main Business
Table 107. Portal Instruments Latest Developments
Table 108. ResMed Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 109. ResMed Non-Invasive Drug Delivery Product Offered
Table 110. ResMed Main Business
Table 111. ResMed Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. ResMed Latest Developments
Table 113. Sensiron AG Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 114. Sensiron AG Non-Invasive Drug Delivery Product Offered
Table 115. Sensiron AG Main Business
Table 116. Sensiron AG Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Sensiron AG Latest Developments
Table 118. Tandem Diabetes Care, Inc. Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 119. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product Offered
Table 120. Tandem Diabetes Care, Inc. Main Business
Table 121. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Tandem Diabetes Care, Inc. Latest Developments
Table 123. Teva Pharmaceuticals Industries Ltd. Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 124. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product Offered
Table 125. Teva Pharmaceuticals Industries Ltd. Main Business
Table 126. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Teva Pharmaceuticals Industries Ltd. Latest Developments
Table 1. Non-Invasive Drug Delivery Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Artificial Pancreas
Table 3. Major Players of Needle Free Injector
Table 4. Major Players of Digital Respiratory Devices
Table 5. Major Players of Other
Table 6. Non-Invasive Drug Delivery Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Non-Invasive Drug Delivery Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Non-Invasive Drug Delivery Market Size Market Share by Type (2018-2023)
Table 9. Non-Invasive Drug Delivery Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Non-Invasive Drug Delivery Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Non-Invasive Drug Delivery Market Size Market Share by Application (2018-2023)
Table 12. Global Non-Invasive Drug Delivery Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Non-Invasive Drug Delivery Revenue Market Share by Player (2018-2023)
Table 14. Non-Invasive Drug Delivery Key Players Head office and Products Offered
Table 15. Non-Invasive Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Non-Invasive Drug Delivery Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Non-Invasive Drug Delivery Market Size Market Share by Regions (2018-2023)
Table 20. Global Non-Invasive Drug Delivery Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Non-Invasive Drug Delivery Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Non-Invasive Drug Delivery Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Non-Invasive Drug Delivery Market Size Market Share by Country (2018-2023)
Table 24. Americas Non-Invasive Drug Delivery Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Non-Invasive Drug Delivery Market Size Market Share by Type (2018-2023)
Table 26. Americas Non-Invasive Drug Delivery Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Non-Invasive Drug Delivery Market Size Market Share by Application (2018-2023)
Table 28. APAC Non-Invasive Drug Delivery Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Non-Invasive Drug Delivery Market Size Market Share by Region (2018-2023)
Table 30. APAC Non-Invasive Drug Delivery Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Non-Invasive Drug Delivery Market Size Market Share by Type (2018-2023)
Table 32. APAC Non-Invasive Drug Delivery Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Non-Invasive Drug Delivery Market Size Market Share by Application (2018-2023)
Table 34. Europe Non-Invasive Drug Delivery Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Non-Invasive Drug Delivery Market Size Market Share by Country (2018-2023)
Table 36. Europe Non-Invasive Drug Delivery Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Non-Invasive Drug Delivery Market Size Market Share by Type (2018-2023)
Table 38. Europe Non-Invasive Drug Delivery Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Non-Invasive Drug Delivery Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Non-Invasive Drug Delivery Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Non-Invasive Drug Delivery Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Non-Invasive Drug Delivery Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Non-Invasive Drug Delivery Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Non-Invasive Drug Delivery Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Non-Invasive Drug Delivery Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Non-Invasive Drug Delivery
Table 47. Key Market Challenges & Risks of Non-Invasive Drug Delivery
Table 48. Key Industry Trends of Non-Invasive Drug Delivery
Table 49. Global Non-Invasive Drug Delivery Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Non-Invasive Drug Delivery Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Non-Invasive Drug Delivery Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Non-Invasive Drug Delivery Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Adherium Limited Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 54. Adherium Limited Non-Invasive Drug Delivery Product Offered
Table 55. Adherium Limited Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Adherium Limited Main Business
Table 57. Adherium Limited Latest Developments
Table 58. Capsule Technologies, Inc. Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 59. Capsule Technologies, Inc. Non-Invasive Drug Delivery Product Offered
Table 60. Capsule Technologies, Inc. Main Business
Table 61. Capsule Technologies, Inc. Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Capsule Technologies, Inc. Latest Developments
Table 63. Crossject S.A. Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 64. Crossject S.A. Non-Invasive Drug Delivery Product Offered
Table 65. Crossject S.A. Main Business
Table 66. Crossject S.A. Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Crossject S.A. Latest Developments
Table 68. Diabeloop SA Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 69. Diabeloop SA Non-Invasive Drug Delivery Product Offered
Table 70. Diabeloop SA Main Business
Table 71. Diabeloop SA Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Diabeloop SA Latest Developments
Table 73. HNS International, Inc. Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 74. HNS International, Inc. Non-Invasive Drug Delivery Product Offered
Table 75. HNS International, Inc. Main Business
Table 76. HNS International, Inc. Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. HNS International, Inc. Latest Developments
Table 78. Inovio Pharmaceuticals, Inc. Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 79. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product Offered
Table 80. Inovio Pharmaceuticals, Inc. Main Business
Table 81. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Inovio Pharmaceuticals, Inc. Latest Developments
Table 83. Medtronic Plc. Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 84. Medtronic Plc. Non-Invasive Drug Delivery Product Offered
Table 85. Medtronic Plc. Main Business
Table 86. Medtronic Plc. Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Medtronic Plc. Latest Developments
Table 88. Novartis AG Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 89. Novartis AG Non-Invasive Drug Delivery Product Offered
Table 90. Novartis AG Main Business
Table 91. Novartis AG Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Novartis AG Latest Developments
Table 93. PenJet Corporation Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 94. PenJet Corporation Non-Invasive Drug Delivery Product Offered
Table 95. PenJet Corporation Main Business
Table 96. PenJet Corporation Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. PenJet Corporation Latest Developments
Table 98. PharmaJet Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 99. PharmaJet Non-Invasive Drug Delivery Product Offered
Table 100. PharmaJet Main Business
Table 101. PharmaJet Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. PharmaJet Latest Developments
Table 103. Portal Instruments Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 104. Portal Instruments Non-Invasive Drug Delivery Product Offered
Table 105. Portal Instruments Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Portal Instruments Main Business
Table 107. Portal Instruments Latest Developments
Table 108. ResMed Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 109. ResMed Non-Invasive Drug Delivery Product Offered
Table 110. ResMed Main Business
Table 111. ResMed Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. ResMed Latest Developments
Table 113. Sensiron AG Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 114. Sensiron AG Non-Invasive Drug Delivery Product Offered
Table 115. Sensiron AG Main Business
Table 116. Sensiron AG Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Sensiron AG Latest Developments
Table 118. Tandem Diabetes Care, Inc. Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 119. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product Offered
Table 120. Tandem Diabetes Care, Inc. Main Business
Table 121. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Tandem Diabetes Care, Inc. Latest Developments
Table 123. Teva Pharmaceuticals Industries Ltd. Details, Company Type, Non-Invasive Drug Delivery Area Served and Its Competitors
Table 124. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product Offered
Table 125. Teva Pharmaceuticals Industries Ltd. Main Business
Table 126. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Teva Pharmaceuticals Industries Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Non-Invasive Drug Delivery Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-Invasive Drug Delivery Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Non-Invasive Drug Delivery Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Non-Invasive Drug Delivery Sales Market Share by Country/Region (2022)
Figure 8. Non-Invasive Drug Delivery Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Non-Invasive Drug Delivery Market Size Market Share by Type in 2022
Figure 10. Non-Invasive Drug Delivery in Hospital
Figure 11. Global Non-Invasive Drug Delivery Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Non-Invasive Drug Delivery in Clinic
Figure 13. Global Non-Invasive Drug Delivery Market: Clinic (2018-2023) & ($ Millions)
Figure 14. Non-Invasive Drug Delivery in Other
Figure 15. Global Non-Invasive Drug Delivery Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Non-Invasive Drug Delivery Market Size Market Share by Application in 2022
Figure 17. Global Non-Invasive Drug Delivery Revenue Market Share by Player in 2022
Figure 18. Global Non-Invasive Drug Delivery Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Non-Invasive Drug Delivery Market Size 2018-2023 ($ Millions)
Figure 20. APAC Non-Invasive Drug Delivery Market Size 2018-2023 ($ Millions)
Figure 21. Europe Non-Invasive Drug Delivery Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Non-Invasive Drug Delivery Market Size 2018-2023 ($ Millions)
Figure 23. Americas Non-Invasive Drug Delivery Value Market Share by Country in 2022
Figure 24. United States Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Non-Invasive Drug Delivery Market Size Market Share by Region in 2022
Figure 29. APAC Non-Invasive Drug Delivery Market Size Market Share by Type in 2022
Figure 30. APAC Non-Invasive Drug Delivery Market Size Market Share by Application in 2022
Figure 31. China Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Non-Invasive Drug Delivery Market Size Market Share by Country in 2022
Figure 38. Europe Non-Invasive Drug Delivery Market Size Market Share by Type (2018-2023)
Figure 39. Europe Non-Invasive Drug Delivery Market Size Market Share by Application (2018-2023)
Figure 40. Germany Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Non-Invasive Drug Delivery Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Non-Invasive Drug Delivery Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Non-Invasive Drug Delivery Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 54. APAC Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 55. Europe Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 57. United States Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 58. Canada Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 61. China Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 62. Japan Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 63. Korea Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 65. India Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 66. Australia Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 67. Germany Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 68. France Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 69. UK Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 70. Italy Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 71. Russia Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 72. Spain Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 75. Israel Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 78. Global Non-Invasive Drug Delivery Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Non-Invasive Drug Delivery Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Non-Invasive Drug Delivery Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-Invasive Drug Delivery Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Non-Invasive Drug Delivery Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Non-Invasive Drug Delivery Sales Market Share by Country/Region (2022)
Figure 8. Non-Invasive Drug Delivery Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Non-Invasive Drug Delivery Market Size Market Share by Type in 2022
Figure 10. Non-Invasive Drug Delivery in Hospital
Figure 11. Global Non-Invasive Drug Delivery Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Non-Invasive Drug Delivery in Clinic
Figure 13. Global Non-Invasive Drug Delivery Market: Clinic (2018-2023) & ($ Millions)
Figure 14. Non-Invasive Drug Delivery in Other
Figure 15. Global Non-Invasive Drug Delivery Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Non-Invasive Drug Delivery Market Size Market Share by Application in 2022
Figure 17. Global Non-Invasive Drug Delivery Revenue Market Share by Player in 2022
Figure 18. Global Non-Invasive Drug Delivery Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Non-Invasive Drug Delivery Market Size 2018-2023 ($ Millions)
Figure 20. APAC Non-Invasive Drug Delivery Market Size 2018-2023 ($ Millions)
Figure 21. Europe Non-Invasive Drug Delivery Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Non-Invasive Drug Delivery Market Size 2018-2023 ($ Millions)
Figure 23. Americas Non-Invasive Drug Delivery Value Market Share by Country in 2022
Figure 24. United States Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Non-Invasive Drug Delivery Market Size Market Share by Region in 2022
Figure 29. APAC Non-Invasive Drug Delivery Market Size Market Share by Type in 2022
Figure 30. APAC Non-Invasive Drug Delivery Market Size Market Share by Application in 2022
Figure 31. China Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Non-Invasive Drug Delivery Market Size Market Share by Country in 2022
Figure 38. Europe Non-Invasive Drug Delivery Market Size Market Share by Type (2018-2023)
Figure 39. Europe Non-Invasive Drug Delivery Market Size Market Share by Application (2018-2023)
Figure 40. Germany Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Non-Invasive Drug Delivery Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Non-Invasive Drug Delivery Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Non-Invasive Drug Delivery Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Non-Invasive Drug Delivery Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 54. APAC Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 55. Europe Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 57. United States Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 58. Canada Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 61. China Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 62. Japan Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 63. Korea Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 65. India Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 66. Australia Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 67. Germany Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 68. France Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 69. UK Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 70. Italy Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 71. Russia Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 72. Spain Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 75. Israel Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Non-Invasive Drug Delivery Market Size 2024-2029 ($ Millions)
Figure 78. Global Non-Invasive Drug Delivery Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Non-Invasive Drug Delivery Market Size Market Share Forecast by Application (2024-2029)
